Alcohol and Drugs News on the Internet


Comments (0)       
Combining behavioral interventions with acamprosate and naltrexone therapy for alcohol-dependent patients saved an estimated $3,800 per patient in societal costs compared to providing medical management alone, according to researchers who evaluated data from the COMBINE study.


Read More ยป

Comments

There are currently no comments, be the first to post one.

Post Comment

Name (required)

Email (required)

Website

CAPTCHA image
Enter the code shown above: